Aristo Bio-Tech and Lifescience Limited
Aristo Bio-Tech and Lifescience Limited, headquartered in India, is a prominent player in the biotechnology and life sciences sector. Founded in 2005, the company has established itself as a leader in the development and manufacturing of innovative biopharmaceuticals and healthcare solutions. With a strong operational presence across various regions in India, Aristo Bio-Tech focuses on delivering high-quality products that cater to the evolving needs of the healthcare industry. The company’s core offerings include a diverse range of biopharmaceuticals, including vaccines and therapeutic proteins, distinguished by their advanced formulation and efficacy. Aristo Bio-Tech's commitment to research and development has led to significant milestones, positioning it as a trusted name in the market. With a reputation for excellence and a dedication to improving patient outcomes, Aristo Bio-Tech continues to make strides in the life sciences landscape.
DitchCarbon Score
How does Aristo Bio-Tech and Lifescience Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Salt and Mineral Mining industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aristo Bio-Tech and Lifescience Limited's score of 14 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aristo Bio-Tech and Lifescience Limited's reported carbon emissions
In 2023, Aristo Bio-Tech and Lifescience Limited reported total carbon emissions of approximately 62,750,070 kg CO2e for Scope 1 and about 52,928,470 kg CO2e for Scope 2. This represents a slight increase in Scope 1 emissions from 61,026,770 kg CO2e in 2022, while Scope 2 emissions decreased from 54,904,440 kg CO2e in the previous year. The company has disclosed emissions data for both Scope 1 and Scope 2 but has not provided information on Scope 3 emissions. Despite the fluctuations in emissions, Aristo Bio-Tech has not set specific reduction targets or climate pledges, indicating a potential area for improvement in their sustainability strategy. The company’s emissions intensity per rupee of turnover has shown a marginal improvement, with a value of 0.003 kg CO2e in 2023 compared to 0.0037 kg CO2e in 2022. Overall, while Aristo Bio-Tech and Lifescience Limited has made strides in emissions reporting, the absence of defined reduction initiatives highlights the need for a more robust climate commitment moving forward.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 61,026,770 | 00,000,000 |
| Scope 2 | 54,904,440 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aristo Bio-Tech and Lifescience Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
